New Blood Thinners Pradaxa and Xarelto Concerning Doctors

Posted on behalf of Phillips Law Group on Jun 22, 2012 in Defective Drug

Cardiologists are weary of prescribing the new blood thinners to patients due to growing complaints of risks and deaths that is tied to them. Pradaxa is a cardiovascular pill that was approved by the U. S Food and Drug Administration in October 2010 to prevent strokes in patients with atrial fibrillation, an irregular heartbeat. Xarelto is a pill developed by Johnson & Johnson with Bayer AG for atrial fibrillation. Atrial fibrillation causes blood to collect in a storage chamber of the heart where it can clot and move to the brain.

The drugs were developed to prevent risks of brain hemorrhages and other dangerous bleeding. Doctors are less knowledgeable about Xarelto. Serious bleeding and blood clots can occur if the drugs are not taken properly. An estimate of 542 deaths associated with Pradaxa was reported by the nonprofit Institute for Safe Medication Practices to the FDA in 2011. Theses deaths surpass all other blood thinner medications.

On the other hand, the manufacturers of Xarelto and Pradaxa say it takes time for doctors to best administer new types of treatments outside of the controls of clinical trails.

If you or someone you love has suffered from internal bleeding after taking Pradaxa, contact our dangerous drug attorneys as soon as possible.  You may be eligible to receive compensation for medical bills, lost wages, pain and suffering.  If your loved one has passed away due to the negative side effects of Pradaxa, the deceased's dependants may be able to collect wrongful death damages.

For more information on the legal rights which may be available to Pradaxa injury victims and their families, or to schedule a no obligation consultation with a lawyer, complete the free case evaluation form on this page to begin exploring your legal options.

Back to Top